US Stock Market Move | Most of the Chinese pharmaceutical stocks rose, BEIGENE (ONC.US) by over 9%

On Tuesday, most of the Chinese pharmaceutical stocks rose. As of press time, BeiGene (ONC.US) rose by over 9%, HutchMed (HCM.US) rose by over 4%; and Zai Lab (ZLAB.US) dipped slightly by 0.08%. In terms of news, BeiGene CEO John Oyler mentioned that, according to US Generally Accepted Accounting Principles, the company is expected to achieve a positive operating profit for the full year of 2025 (meaning that operating income will exceed the sum of operating costs, sales expenses, management expenses, and research and development expenses).